FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds

270,995 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

R2: 117
R2B: 0
R3: 21,787
R4: 158,444
R4B: 43,719
R5: 32,499
R6: 2,222

By Authority

none: 189,580
hl7: 74,857
ihe: 1,324
national: 3,888
who: 1,346

By Realm

none: 183,568
au: 736
be: 606
br: 400
ca: 1,464
ch: 1,776
cl: 564
cr: 117
cz: 862
de: 2,090
dk: 1,497
ee: 260
eu: 967
fi: 87
fr: 3,334
il: 328
in: 163
it: 116
jp: 174
kr: 30
nl: 2,247
no: 125
nz: 240
pl: 258
pt: 50
se: 161
stt: 116
tw: 1,414
uk: 6
us: 23,032
uv: 44,063
vn: 108
other: 6

Start Prev Rows 227400 - 227600 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth	Usage #
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.532.json	Pregnancy	active	2025-01	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.56.json	Coronary Artery Disease No MI	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.57.json	Coronary Artery Disease No MI	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.58.json	Initial Myocardial Infarction	active	2024-02	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.589.json	End Stage Renal Disease	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.59.json	Asthma	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.590.json	End Stage Renal Disease	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.60.json	Asthma	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.61.json	Asthma	active	2025-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.73.json	Primary Open Angle Glaucoma	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.74.json	Primary Open Angle Glaucoma	active	2025-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.76.json	Diabetic Retinopathy	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.80.json	Diabetic Retinopathy	active	2025-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.859.json	Left Ventricular Systolic Dysfunction	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.860.json	Moderate or Severe	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.861.json	Moderate or Severe LVSD	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.91.json	Prostate Cancer	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.2.92.json	Prostate Cancer	active	2025-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1002.json	Chronic Kidney Disease, Stage 5	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1005.json	Dementia and Mental Degenerations	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1006.json	Standardized Tools Score for Assessment of Cognition	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1007.json	Medical Reason	active	2022-03	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1008.json	Patient Reason	active	2022-03	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1010.json	Cancer	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1011.json	Occupational Therapy Evaluation	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1012.json	Patient Provider Interaction	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1018.json	Psych Visit for Family Psychotherapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1023.json	Behavioral or Neuropsych Assessment	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1026.json	Radiation Treatment Management	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1027.json	Chemotherapy Administration	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1028.json	Standardized Pain Assessment Tool	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1090.json	Moderate or Severe LVSD	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1091.json	Left Ventricular Systolic Dysfunction	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1092.json	Moderate or Severe	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1134.json	Ejection Fraction	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1139.json	ACE Inhibitor or ARB or ARNI	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1140.json	Patient Reason for ACE Inhibitor or ARB Decline	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1141.json	Psychoanalysis	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1151.json	Renal Failure Due to ACE Inhibitor	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1170.json	Tobacco User	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1174.json	Beta Blocker Therapy	active	2021-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1176.json	Heart Rate	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1177.json	Allergy to Beta Blocker Therapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1178.json	Intolerance to Beta Blocker Therapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1184.json	Beta Blocker Therapy for LVSD	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1187.json	Group Psychotherapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1189.json	Tobacco Non User	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1190.json	Tobacco Use Cessation Pharmacotherapy	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1193.json	Cardiac Pacer	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1211.json	Allergy to ACE Inhibitor or ARB	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1212.json	Intolerance to ACE Inhibitor or ARB	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1240.json	Annual Wellness Visit	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1241.json	Acute and Subacute Iridocyclitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1251.json	Macular Exam	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1259.json	Limited Life Expectancy	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1278.json	Tobacco Use Screening	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1283.json	Level of Severity of Retinopathy Findings	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1285.json	Ophthalmological Services	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1320.json	Macular Edema Findings Present	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1332.json	Cognitive Assessment	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1333.json	Cup to Disc Ratio	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1334.json	Optic Disc Exam for Structural Abnormalities	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1409.json	Burn Confined to Eye and Adnexa	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1410.json	Cataract Secondary to Ocular Disorders	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1411.json	Cataract Surgery	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1412.json	Cataract Congenital	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1413.json	Cataract Mature or Hypermature	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1414.json	Cataract Posterior Polar	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1415.json	Certain Types of Iridocyclitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1416.json	Chronic Iridocyclitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1417.json	Cloudy Cornea	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1418.json	Corneal Edema	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1419.json	Disorders of Cornea Including Corneal Opacity	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1423.json	Glaucoma	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1424.json	Hereditary Corneal Dystrophies	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1426.json	Hypotony of Eye	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1427.json	Injury to Optic Nerve and Pathways	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1428.json	Central Corneal Ulcer	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1430.json	Open Wound of Eyeball	active	2021-04	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1432.json	Pathologic Myopia	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1433.json	Posterior Lenticonus	active	2021-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1438.json	Retrolental Fibroplasias	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1443.json	Traumatic Cataract	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1444.json	Uveitis	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1445.json	Vascular Disorders of Iris and Ciliary Body	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1446.json	Visual Field Defects	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1448.json	Amblyopia	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1450.json	Choroidal Degenerations	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1451.json	Choroidal Detachment	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1452.json	Choroidal Hemorrhage and Rupture	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1453.json	Degeneration of Macula and Posterior Pole	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1454.json	Degenerative Disorders of Globe	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1455.json	Diabetic Macular Edema	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1457.json	Disorders of Optic Chiasm	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1458.json	Disorders of Visual Cortex	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1459.json	Disseminated Chorioretinitis and Disseminated Retinochoroiditis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1460.json	Focal Chorioretinitis and Focal Retinochoroiditis	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1461.json	Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1462.json	Hereditary Choroidal Dystrophies	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1463.json	Hereditary Retinal Dystrophies	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1465.json	Nystagmus and Other Irregular Eye Movements	active	2021-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1466.json	Optic Atrophy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1467.json	Optic Neuritis	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1468.json	Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1469.json	Other Background Retinopathy and Retinal Vascular Changes	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1471.json	Other Disorders of Optic Nerve	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1473.json	Other Endophthalmitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1475.json	Prior Penetrating Keratoplasty	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1477.json	Purulent Endophthalmitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1478.json	Retinal Detachment with Retinal Defect	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1479.json	Retinal Vascular Occlusion	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1480.json	Other Proliferative Retinopathy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1482.json	Separation of Retinal Layers	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1483.json	Visual Acuity 20/40 or Better	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1491.json	Major Depressive Disorder Active	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1492.json	Psych Visit Diagnostic Evaluation	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1496.json	Psych Visit Psychotherapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1530.json	Speech and Hearing Evaluation	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1558.json	Morgagnian Cataract	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1559.json	Macular Scar of Posterior Polar	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1560.json	Best Corrected Visual Acuity Exam Using Snellen Chart	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1561.json	Medications for Above Normal BMI	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1562.json	Medications for Below Normal BMI	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1563.json	Underweight	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1566.json	Adult Depression Medications	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1567.json	Adolescent Depression Medications	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1568.json	Follow Up for Adult Depression	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1569.json	Follow Up for Adolescent Depression	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1570.json	Referral for Adolescent Depression	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1571.json	Referral for Adult Depression	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1572.json	High Intensity Statin Therapy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1573.json	LDL Cholesterol	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1574.json	Low Intensity Statin Therapy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1575.json	Moderate Intensity Statin Therapy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1576.json	Outpatient Encounters for Preventive Care	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1578.json	Follow Up Within 4 Weeks	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1580.json	Referral to Primary Care or Alternate Provider	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1581.json	Lifestyle Recommendation	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1582.json	Patient Declined	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1583.json	Referral or Counseling for Alcohol Consumption	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.1584.json	Hospice Care Ambulatory	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.3000.json	Metformin	active	2019-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.319.json	Prostate Cancer	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.320.json	Bone Scan	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.326.json	Primary Open Angle Glaucoma	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.327.json	Diabetic Retinopathy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.353.json	End Stage Renal Disease	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.362.json	Asthma	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.366.json	Arrhythmia	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.367.json	Atrioventricular Block	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.368.json	Cardiac Pacer in Situ	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.369.json	Coronary Artery Disease No MI	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.370.json	Hypotension	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.371.json	Cardiac Surgery	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.376.json	Heart Failure	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.378.json	Pregnancy	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.398.json	Prostate Cancer Treatment	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.399.json	Salvage Therapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.401.json	Prostate Specific Antigen Test	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.403.json	Initial Myocardial Infarction	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.412.json	Bradycardia	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.451.json	Pain Warranting Further Investigation for Prostate Cancer	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.471.json	Bilateral Oophorectomy	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.485.json	Chemotherapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.526.3.509.json	Tobacco Use Cessation Counseling	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1498.json	Medications for Above Normal BMI	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1499.json	Medications for Below Normal BMI	active	2022-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1519.json	Follow Up for Above Normal BMI	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1523.json	Follow Up for Above Normal BMI	active	2017-08	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1524.json	Follow Up for BMI Outside Normal Parameters	active	2024-02	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1525.json	Follow Up for Above Normal BMI	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1526.json	Follow Up for Above Normal BMI	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1527.json	Referrals Where Weight Assessment May Occur	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1528.json	Follow Up for Below Normal BMI	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1549.json	Follow Up for Below Normal BMI	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1550.json	Follow Up for Below Normal BMI	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1551.json	Follow Up for Below Normal BMI	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1578.json	Palliative Care	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1579.json	Palliative or Hospice Care	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1608.json	Encounter to Document Medications	active	2025-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1609.json	Encounter to Document Medications	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1610.json	Referrals Where Weight Assessment May Occur	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1751.json	Encounter to Evaluate BMI	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1834.json	Encounter to Document Medications	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.1917.json	Encounter to Document Medications	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.695.json	Encounter to Evaluate BMI	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.885.json	Encounter to Evaluate BMI	active	2018-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1.886.json	Encounter to Evaluate BMI	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1475.json	Referral to Primary Care or Alternate Provider	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1476.json	Pharmacologic Therapy for Hypertension	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1482.json	Laboratory Tests for Hypertension	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1497.json	Encounter to Screen for Blood Pressure	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1508.json	Lifestyle Recommendation	active	2025-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1509.json	Weight Reduction Recommended	active	2022-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1510.json	Weight Reduction Recommended	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1511.json	Dietary Recommendations	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1512.json	Dietary Recommendations	active	2025-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1514.json	Dietary Recommendations	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1515.json	Dietary Recommendations	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113883.3.600.1516.json	Exercise Class	active	2017-05	us	hl7	1